cbdMD (YCBD) Net Margin Growth (5y) (2021 - 2026)
cbdMD (YCBD) Net Margin Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3,018.00 |
| Dec 31, 2025 | 6,584.00 |
| Sep 30, 2025 | 3,455.00 |
| Jun 30, 2025 | 5,708.00 |
| Mar 31, 2025 | -18,848.00 |
| Dec 31, 2024 | -14,281.00 |
| Sep 30, 2024 | -13,651.00 |
| Jun 30, 2024 | 27,410.00 |
| Mar 31, 2024 | 31,844.00 |
| Dec 31, 2023 | 27,143.00 |
| Sep 30, 2023 | -35,944.00 |
| Jun 30, 2023 | -5,641.00 |
| Mar 31, 2023 | -8,296.00 |
| Dec 31, 2022 | 8,165.00 |
| Sep 30, 2022 | -13,457.00 |
| Jun 30, 2022 | -36,422.00 |
| Mar 31, 2022 | -1,005.00 |
| Dec 31, 2021 | 11,295.00 |